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INTRODUCTION
Analysis of uncultured fetal cells by fluorescence in situ
hybridization (FISH) has been used as a rapid alternative in
screening for common chromosomal aneuploidies (1, 2).
Although FISH usually takes only 24 to 48 hr, it is expensive
and intensively laborious. Recently, quantitative fluorescent
PCR (QF-PCR) of single tandem repeats (STRs) has been
developed for rapid prenatal diagnosis of aneuploidies (3, 4).
This approach has been used extensively by several groups on
research basis (5-10), and the diagnosis of aneuploidies by
QF-PCR of STRs has now been validated as a reliable method
applicable in many laboratories.
In this study, we investigated the clinical feasibility of QF-
PCR for rapid prenatal diagnosis of trisomy 21. 
MATERIALS AND METHODS
Genomic DNA extraction was performed on the cell pel-
let obtained from 1 to 2 mL of amniotic fluid from 200 nor-
mal samples and 21 samples with trisomy 21. The karyotypes
of all amniotic fluid samples were performed previously by
conventional cytogenetic analysis. DNA was extracted by
incubating cell pellets with InstaGene Matrix (Bio-Rad Labo-
ratories, Hercules, CA, U.S.A.). A single tube multiplex PCR
was carried out by STR markers specific for chromosome 21.
D21S11, D21S1411, and D21S1270 (10) were used to test
all samples for chromosome 21. D21S1412 (11) was added
to test samples found to be homozygous for the first three
STR (Table 1). The QF-PCR amplification of STR markers
was performed in a total volume of 25  L containing 1.5 mM
MgCl2, 200  m/L dNTP, 10-30 pmol of each primer, PCR
buffer, 2U Taq polymerase, and 10  L genomic DNA. After
the initial denaturation at 94℃for 5 min, hot start PCR was
followed by 25 cycles of 94℃for 35 sec, 58℃for 35 sec, 72
℃for 40 sec and final extension was for 5 min at 72℃. For
fragment analysis of PCR products, ABI 3100 and GeneScan
3.7 (Applied Biosystems, Foster City, CA, U.S.A.) were used. 
The statistical analysis of the heterozygosity for each STR
marker between the published population (10) and the Korean
population were analyzed using the Z-test. A p-value >1.96
was taken as significant.
RESULTS
The majority of normal samples showed diallelic peaks
with a ratio of 1:1 for each STR marker (Fig. 1). Among nor-
mal samples, the ranges of diallelic peaks were 1.0-1.3 for
D21S11, 1.0-1.4 for D21S1411 and 1.0-1.5 for D21S1270
(Table 2). Down syndrome samples that confirmed karyotypes
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Rapid Prenatal Diagnosis of Down Syndrome Using Quantitative 
Fluorescent PCR in Uncultured Amniocytes
Rapid prenatal diagnosis of common chromosome aneuploidies have been suc-
cessful through quantitative fluoresent PCR (QF-PCR) assays and small tandem
repeat (STR) markers. The purpose of our study was to investigate the clinical
feasibility for rapid prenatal detection of Down syndrome using the quantitative flu-
orescent PCR in uncultured amniocytes. DNA was extracted from uncultured amni-
otic fluid of normal karyotype (n=200) and of Down syndrome (n=21). It was ampli-
fied using QF-PCR with four STR markers located on chromosome 21. Among
normal samples, the ranges of diallelic peaks for at least one STR marker were
1.0-1.3 for D21S11, 1.0-1.4 for D21S1411 and 1.0-1.5 for D21S1270. Down syn-
drome samples showed trisomic triallelic patterns or trisomic diallelic patterns. The
sensitivity, specificity, and efficiency of the assay for detecting Down syndrome
were 95.4%, 100%, and 99.5%, respectively. Rapid prenatal diagnosis of Down
syndrome using QF-PCR is a reliable technique that aids clinical management of
pregnancy.
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with 47,+21 showed trisomic triallelic patterns with an allele
peak ratio 1:1:1, or trisomic diallelic patterns with an allele
peak ratio 2:1 (Fig. 1). However, one case that showed low-
level mosaicism with a karyotype of 47,XX,+21[23]/46,XX
[218] failed to be detected by QF-PCR. In complete trisom-
ic 21 samples, the ranges of diallelic peaks were 1.6-2.4 for
D21S11, 2.2-2.7 for D21S1411, and 1.7-2.9 for D21S1270
(Table 3).  
*Reference: Mann, et al. 2001 (10).
Marker Labeling Allele range (bp) Location
D21S11 6-FAM 214-242 21q21
D21S1411 NED 266-319 21q22.3
D21S1270 6-FAM 285-340 21q21-22.1
D21S1412 6-FAM 384-414 21q22.2
Table 1. STR markers used for quantitative fluorescent PCR*
Mean SD Range
Ratio of peak areas in 
heterozygous samples Homozygous 
samples (n)
Heterozygous
samples (n)
Marker
D21S11 165 35 1.1 0.11 1.0-1.3
D21S1411 169 31 1.1 0.17 1.0-1.4
D21S1270 167 33 1.2 0.12 1.0-1.5
D21S1412 2 1 1.1 0.11 1.0-1.2
Table 2. Polymorphism and ratio of peak areas in 200 normal
samples
Fig. 1. Electrophoregram of the QF-PCR products from normal and trisomy 21 samples. Fragment size in bp shown on horizontal axis,
arbitrary fluorescence units shown on vertical axis. Markers labelled according to locus, size, and peak areas. Normal diploid sample: all
markers are heterozygous and exhibit two peaks with a 1:1 ratio. Trisomy 21 sample: chromosome 21 markers exhibit three peaks with a
1:1:1 ratio or two peaks with a 2:1 ratio.
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All but one normal samples were heterozygous and infor-
mative for at least one STR marker (Table 4). 
The sensitivity, specificity, and efficiency of QF-PCR for
the detection of Down syndrome were 95.4%, 100%, and
99.5%, respectively. The false positive and the false nega-
tive rates were 0% (0/200) and 4.7% (1/21), respectively.
All results were obtained within 24 to 48 hr.
DISCUSSION
QF-PCR for the detection of chromosome specific repeat-
ed sequences has been improved to include several STR (3,
4). It is based on the incorporation of fluorochromes into the
products of PCR amplification via oligonucleotide primers
specific for each STR and on the assumption that, within the
early exponential phase of PCR amplification, the amount
of specific STR produced is proportional to the quantity of
initial target sequence (12). In normal heterozygotes, the ratio
of the fluorescent intensity of the two peaks should be close
to 1:1. If the STR marker is highly polymorphic, few nor-
mal subjects should be homozygotes and show one peak. In
a trisomic patient, the three doses of an STR marker can be
detected either as three peaks of fluorescent intensity with a
ratio 1:1:1 (trisomic triallelic) or as a pattern of two peaks
with a ratio 2:1 (trisomic diallelic). Using the high polymor-
phism of the STR markers, very few trisomic patients should
show a single peak of fluorescent intensity (4).
Our results present that the fluorescent intensity ratios
showed a definite difference between normal disomic dial-
lelic samples and diallelic trisomy 21 samples. 
In the present study, we used the markers as published pre-
viously. It was shown that heterozygosity of markers was low
in our population compared to the published data (Table 5).
At the D21S11 and D21S1411 markers, a significant dif-
ferences were found. We expected a difference of genetic diver-
sity between an ethnic groups and it was supported by other
previous reports (13-16). 
Although 4 samples showed heterozygous for only one STR,
even after using the extra marker, the use of combined STR
markers could reduce the likelihood of homozygosity and
consequently, the frequency of uninformative STR patterns.
Only one out of 220 samples was homozygous for all STR
tested (Table 4). As a results, we emphasize that the infor-
mative rate of our experiment is prominent than other stud-
ies so far (5, 8, 9, 16).
Yoon et al. reported three false positive in the multiplex
QF-PCR using two of STR markers for Down syndrome (16).
As it is well known, the preferential amplification of multi-
plex PCR is a potential problem that result in an incorrect
genetic typing and is effected by low denaturation tempera-
tures, low amount of DNA, and differential allelic priming.
In this study, there were no false positive results from mul-
tiplex QF-PCR using three of STR markers. It is reported
that a maximum primer set used in the multiplex QF-PCR
is twelve up to now (10).
One case of low level mosaicism for trisomy 21 with a karyo-
type of 47,XX,+21[23]/46,XX[218] resulted in a false nega-
tive result. Several studies reported that mosaicism for trisomy
was able to be detected by QF-PCR (10, 11), but based on
our own and other published experiences, mosaicism, mater-
nal contamination, structural abnormality, deletion and dupli-
cation syndrome are not likely to be detected by the QF-PCR
technique (8, 9). However, it is possible that future develop-
ment, such as the use of extensive panel of markers to cover
other key chromosomes, will result in significant improve-
ments in the detection rate. 
An advantage of using QF-PCR technique is that it is less
time consuming and less laborious and this assay is useful
on small volumes of amniotic fluid (1-2 mL). In this study,
some results were obtained within 8 hr.
Our experiment demonstrates that QF-PCR can provide
a rapid and accurate clinical method for prenatal identifica-
tion of Down syndrome and also serve as an adjunctive test
to help cytogenetics to reduce significant amounts of emo-
tional stress experienced by patients and physicians. In fur-
Mean SD Range
Ratio of peak areas 
in diallelic samples Diallelic 
samples (n)
Monoallelic
samples (n)
Triallelic 
samples (n)
Marker
D21S11 9 9 2 2.0 0.34 1.6-2.4
D21S1411 5 9 6 2.3 0.14 2.2-2.7
D21S1270 5 15 0 2.2 0.55 1.7-2.9
*One case with mosaicism was excluded.
Table 3. Polymorphism and ratio of peak areas in trisomy 21
samples*
STR marker Homozygous % (n) Heterozygous % (n)
D21S11 16.8 (37/220) 83.2 (183/220)
D21S1411 16.8 (37/220) 83.2 (183/220)
D21S1270 15.0 (33/220) 85.0 (187/220)
D21S11+D21S1411+D21S1270 1.4 (3/220)
D21S11+D21S1411+D21S1270
+D21S1412 0.45 (1/220)
*One of false negative was excluded.
Table 4. Evaluation for each STR marker and combined STR
markers*
STR marker
Heterozygous frequency
Reference
(Mann et al., 
2001)
Reference
(Mann et al., 
2001)
Present study
(Korean
group)
Present study
(Korean
group)
Allele range (bp)
D21S11 0.9 0.83 214-242 239-268
D21S1411 0.933 0.83 266-319 294-338
D21S1270 0.86 0.85 285-340 292-329
Table 5. Evaluation of markers in the Korean population344 M.-H. Lee, H.-M. Ryu, D.-J. Kim, et al.
ther studies, we will test a larger scale population with expand-
ed panel of markers for other numerical aberrations, such as
trisomy 13 or 18 and sex chromosome aneuploidies.
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